Bioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia
1 other identifier
observational
58
1 country
1
Brief Summary
We aimed to investigate the role of bioimpedance spectroscopy for the diagnosis of hyponatremia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 20, 2013
CompletedFirst Posted
Study publicly available on registry
April 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedNovember 3, 2014
October 1, 2014
6 months
April 20, 2013
October 30, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of volume status measured by bioimpedance spectroscopy
BIOIMPEDANCE SPECTROSCOPY: Overhydration (OH) measurement by Body Composition Monitor (Fresenius Medical Care) Negative values of "OH" indicating Hypovolemia and positive values for hypervolemia in hyponatremic patients.
Six months
Secondary Outcomes (1)
Laboratory data and echocardiography
6 Months
Study Arms (2)
Hypovolemic hyponatremia
Negative values of "Overhydration" measured by Bioimpedance spectroscopy
Hypervolemic hyponatremia
Positive values of "Overhydration" measured by Bioimpedance spectroscopy
Eligibility Criteria
Patients admitted to Bulent Ecevit University Hospital with the presentation of hyponatremia
You may qualify if:
- Willing to participate in the study with written informed consent
- Older than 18-years
You may not qualify if:
- The presence of pacemaker or defibrillator
- Artificial joints, pin or amputation
- Pregnancy or lactating.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bulent Ecevit University Hospital
Zonguldak, 67300, Turkey (Türkiye)
Related Publications (2)
Hur E, Usta M, Toz H, Asci G, Wabel P, Kahvecioglu S, Kayikcioglu M, Demirci MS, Ozkahya M, Duman S, Ok E. Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis. 2013 Jun;61(6):957-65. doi: 10.1053/j.ajkd.2012.12.017. Epub 2013 Feb 15.
PMID: 23415416BACKGROUNDKose SB, Hur E, Magden K, Yildiz G, Colak D, Kucuk E, Toka B, Kucuk H, Yildirim I, Kokturk F, Duman S. Bioimpedance spectroscopy for the differential diagnosis of hyponatremia. Ren Fail. 2015 Jul;37(6):947-50. doi: 10.3109/0886022X.2015.1040418. Epub 2015 Apr 27.
PMID: 25915455DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Ender Hur, Assoc.Prof.
Bulent Ecevit University Medical School, Division of Nephrology, Zonguldak, Turkey
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor Doctor
Study Record Dates
First Submitted
April 20, 2013
First Posted
April 24, 2013
Study Start
February 1, 2013
Primary Completion
August 1, 2013
Study Completion
September 1, 2013
Last Updated
November 3, 2014
Record last verified: 2014-10